Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$331M
-
Value change
-
+$19.9M
-
Put/Call ratio
-
0
-
Number of buys
-
50
-
Number of sells
-
-35
-
Price
-
$16.86
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q4 2015
103 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2015.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 54.8M outstanding shares and own 35.8% of the company stock.
Largest 10 shareholders include FMR LLC (3.88M shares), RHO CAPITAL PARTNERS INC (2.67M shares), Sectoral Asset Management Inc (1.21M shares), EverPoint Asset Management, LLC (900K shares), BlackRock Fund Advisors (853K shares), MILLENNIUM MANAGEMENT LLC (781K shares), VANGUARD GROUP INC (657K shares), JENNISON ASSOCIATES LLC (656K shares), CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD (618K shares), and FRANKLIN RESOURCES INC (611K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.